Discover 942 paid clinical trials in Portland, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 942
Active & Responsive
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
for
Small Cell Lung Cancer
Location: Portland OR, Chicago IL, Nashville TN, Buffalo NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06780137
Phase1, Phase2, Recruiting
Active & Responsive
A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple Myeloma
for
Multiple Myeloma
Location: Portland OR, Seattle WA, Salt Lake City UT,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT04133636
Phase2, Recruiting
Active & Responsive
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
for
Asthma
Location: Portland OR, Clackamas OR, Boise ID, Sacramento CA,
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Sex: All
Age: 12+
Code: NCT06664619
Phase3, Recruiting
Active & Responsive
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
for
Solid Tumor, Non-Small Cell Lung Cancer, Head and Neck Cancer,
Location: Portland OR, Santa Rosa CA, Billings MT, Glendale CA,
Sponsor: Inhibrx Biosciences, Inc
Sex: All
Age: 18+
Code: NCT04198766
Phase1, Phase2, Recruiting
Active & Responsive
Study to Compare the Effectiveness and Safety of Golcadomide Plus R-CHOP vs Placebo Plus R-CHOP in Participants With Previously Untreated High-risk Large B-cell Lymphoma
for
Large B-cell Lymphoma
Location: Portland OR, Victoria, Reno NV, Phoenix AZ,
Sponsor: Celgene
Sex: All
Age: 18 - 70+
Code: NCT06356129
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC